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The epithelial signaling protein and transcriptional regulator b-catenin has recently been implicated in
hematopoietic dendritic cell (DC) differentiation as well as in DC-mediated tolerance. We here observed that
epidermal Langerhans cells (LCs) but not interstitial/dermal DCs express detectable b-catenin. LCs are unique
among the DC family members in that LC networks critically depend on epithelial adhesion molecules as well as
on the cytokine transforming growth factor-b1 (TGF-b1). However, despite the important functions of LCs in the
immune system, the molecular mechanisms governing LC differentiation and maintenance remain poorly
defined. We found that TGF-b1 induces b-catenin in progenitor cells undergoing LC differentiation and that
b-catenin promotes LC differentiation. Vitamin D, another epidermal signal, enhanced TGF-b1-mediated b-catenin
induction and promoted the expression of multiple epithelial genes by LCs. Moreover, full-length vitamin D
receptor (VDR) promoted, whereas a truncated VDR diminished, the positive effects of ectopic b-catenin on LC
differentiation. Therefore, we here identified b-catenin as a positive regulator of LC differentiation in response to
TGF-b1 and identified a functional interaction between b-catenin and VDR in these cells.
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INTRODUCTION
Langerhans cells (LCs) represent abundantly occurring and
evolutionarily highly conserved dendritic cells (DCs) specifi-
cally located in the stratified epithelial tissues. LCs are unique
among DC family members in that they express epithelial-
type adhesion molecules, allowing them to form a tight
three-dimensional network in the basal and suprabasal
epidermal keratinocyte layers. LCs are potent inducers of
adaptive immune responses and possess innate immune
functions (Romani et al., 2012a,b). However, the epithelial
microenvironmental mechanisms underlying LC development,
adhesion, and function are still poorly defined.
b-Catenin is a transcriptional regulator of the Wnt signaling
pathway. It interacts with the intracellular tail of cadherins
such as E-cadherin and thereby provides a link of cadherins to
the cytoskeleton (Van den Bossche et al., 2012). We previously
demonstrated that E-cadherin is induced by transforming growth
factor-b1 (TGF-b1) during LC differentiation from CD34þ
human hematopoietic progenitor cells (HPCs) (Riedl et al.,
2000b). A hallmark of in vitro generated LCs is their tendency
to form large, macroscopically visible homotypic cell clusters.
These LC clusters are at least partially mediated through
E-cadherin adhesion (Riedl et al., 2000b). Moreover, we
showed that in response to mechanical cluster disaggre-
gation, LCs undergo activation/maturation and specific
E-cadherin engagement immediately after cluster disruption
inhibited their maturation (Riedl et al., 2000a). Murine studies
subsequently demonstrated that this effect is mediated by b-
catenin signaling due to the loss of E-cadherin adhesion and that
cluster-disrupted DCs exert a tolerogenic function upon transfer
in vivo (Jiang et al., 2007; Vander Lugt et al., 2011). In line with
this, DC maturation is paralleled by the inhibition of glycogen
synthase kinase 3b (GSK3b) and enhancement of b-catenin
signaling (Alessandrini et al., 2011). Recently, it was shown that
intestinal lamina propria DCs and macrophages express higher
levels of transcriptionally active b-catenin as compared with
splenic DCs, and the deletion of b-catenin from CD11cþ cells
promoted the occurrence of intestinal autoimmunity
(Manicassamy et al., 2010), demonstrating that b-catenin is
critically required for DC capacity to maintain tolerance.
Epidermal LCs express high levels of E-cadherin because of
TGF-b1 signaling, whereas dermal/interstitial DCs lack sub-
stantial E-cadherin expression (Platzer et al., 2004). E-cadherin
retains b-catenin at the cell membrane and prevents it from
degradation (Gumbiner, 1996). With the exception of the
above-mentioned study (Manicassamy et al., 2010), data on
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the expression distribution of b-catenin in DC subsets are
lacking. Nevertheless, a role of b-catenin in DC subset
differentiation has been demonstrated. One study showed
that DC and monocyte differentiation was inhibited by
b-catenin agonistic stimuli, Wnt3a and LiCl (Valencia et al.,
2010). Another study reported that SB216763 or LiCl inhibited
monocyte-derived DC differentiation from human monocytes
(Rodionova et al., 2007). In contrast, it has been shown that
murine bone marrow–derived DC and human DC differentia-
tion was promoted by b-catenin activation (Zhou et al., 2009).
LCs and interstitial-type/dermal DCs can be generated from
human CD34þ HPCs in response to specific cytokine combi-
nations. In this differentiation model, interstitial/dermal DCs
develop from monocyte intermediates in the absence of TGF-
b1. Conversely, the addition of TGF-b1 early after culture
onset redirects monocyte to LC differentiation. Data on
b-catenin expression and function in cells undergoing LC
versus monocyte differentiation are lacking. As LCs represent a
unique DC subset that has recently been shown to negatively
regulate immune responses (Kaplan, 2010), we here studied
the role of b-catenin in these cells in vitro.
RESULTS
TGF-b1 induces b-catenin expression during LC subset
differentiation
We analyzed b-catenin expression using human skin-resident
DCs. LCs identified as HLA-DRþ epidermal cells express
similar high b-catenin levels as observed for keratinocytes.
Conversely, dermal HLA-DRþ cells (dermal DCs and macro-
phages) exhibit low to undetectable b-catenin expression
(Figure 1a). LCs can be generated in vitro from human
CD34þ HPCs in response to TGF-b1 stimulation (Strobl
et al., 1996). Specifically, the addition of TGF-b1 to a basic
cytokine combination comprising GM-CSF, stem cell factor,
fms-related tyrosine kinase 3 ligand, and tumor necrosis
factor-a in defined serum-free medium results in LC
differentiation from CD34þ HPCs. Omission of TGF-b1
from these cultures abrogates LC differentiation in favor of
CD14þCD11bþ monocytes. Therefore, in this model TGF-b1
induces LCs at the expense of monocyte differentiation. It is to
be noted that percentages of LCs drop substantially upon
omission of TGF-b1 from cultures between day 4 and day 7,
indicating that in vitro LC differentiation is critically dependent
on the continuous presence of TGF-b1 (Supplementary Figure
S1a, b online). Quantitative real-time reverse-transcriptase–
PCR (qRT–PCR) analysis revealed that b-catenin is expressed
at substantially higher levels by day 7–generated cells from
TGF-b1-supplemented LC generation cultures as compared
with TGF-b1-nonsupplemented monocyte generation cultures
(Figure 1b).
Because TGF-b1 instructs LC differentiation from HPCs, we
studied whether b-catenin is induced in progenitor cells at
early time points upon TGF-b1 addition. This was indeed the
case (Figure 1c). Moreover, TGF-b1-mediated b-catenin
induction did not require new protein synthesis as revealed
from cyclohexamide (CHX) addition experiments (Figure 1c).
Flow cytometry and immunoblot analyses confirmed that
TGF-b1-induced CD207þCD1aþ LCs expressed higher levels
of b-catenin compared with CD207CD1a cells from the
same cultures. Moreover, the majority of CD14þ or CD14
cells from TGF-b1-nonsupplemented monocyte generation
cultures lacked detectable b-catenin expression (Figure 1d
and e). Therefore, LC differentiation is marked by the induc-
tion of high levels of b-catenin, congruent with the observa-
tion that among skin monocyte/DC subsets only LCs expressed
substantial b-catenin levels.
b-Catenin promotes LC differentiation
We analyzed whether b-catenin promotes LC differentiation.
FACS and western blot analyses of gene-transduced cells
confirmed that the forced retroviral expression or lentiviral
short hairpin RNA–mediated knockdown of b-catenin modu-
lated b-catenin levels (Supplementary Figure S2a–d online).
Ectopic b-catenin augmented the generation of CD1aþ
CD207þ LCs and this effect required TGF-b1. In the absence
of TGF-b1, b-catenin instead promoted the generation of
CD1aþ cells lacking CD207þ (Figure 2a). In contrast, knock-
down of b-catenin during LC generation resulted in reduced
percentages of LCs (Figure 2b).
GSK3b is known to phosphorylate b-catenin at serine and
threonine residues in the NH2-terminal region, which results
in proteasome-mediated degradation of b-catenin (Orford
et al., 1997). As a result of GSK3b inhibition, b-catenin
protein is stabilized and accumulates in the cytoplasm and
can translocate into the nucleus (Polakis, 2000). We added the
GSK3b inhibitor SB216763 or LiCl, another b-catenin agonist,
to LC or monocyte differentiation cultures as schematically
shown in Figure 2c and Supplementary Figure S3a online. As
expected, both compounds increased b-catenin protein levels
in differentiated LCs (Supplementary Figures S2e and f and S3b
online). SB216763 or LiCl promoted LC differentiation in the
presence of TGF-b1 (Figure 2d and Supplementary Figure S3c
online). This effect was accompanied by increased numbers of
macroscopically visible LC clusters (Figure 2e and
Supplementary Figure S3d online). In addition, elevated
b-catenin levels failed to modulate cell proliferation as evi-
denced from carboxyfluorescein succinimidyl ester labeling
experiments (Figure 2f and Supplementary Figure S3e online).
Together, these results demonstrate that enforced b-catenin
expression in HPCs promotes their differentiation into LCs.
TGF-b1 induces multiple epithelial genes during LC
differentiation
b-Catenin is a key regulator of adherens junctions and cell
differentiation. Consistently, b-catenin activation enhanced LC
cluster formation (Figure 2e and Supplementary Figure S3d
online), an effect at least partially dependent on E-cadherin
adhesion (Riedl et al., 2000b). In addition to E-cadherin, LCs
express other epithelial adhesion–associated molecules such
as claudin-1, epithelial cell adhesion molecule (EpCAM), and
TROP2 (Riedl et al., 2000b; Zimmerli and Hauser, 2007;
Eisenwort et al., 2011; Gaiser et al., 2012). We analyzed
whether TGF-b1-dependent LCs express multiple epithelial
adhesion molecules. TGF-b1-induced LCs express cytokeratin-
18 (CK18), cytokeratin-8 (CK8), ZO3, JAM-1, and occludin
(Ocln) at mRNA levels (Figure 3b). Conversely, cells from
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monocyte cultures (TGF-b1) showed low to undetectable
epithelial gene expression levels (Figure 3b). Flow cytometry
analysis confirmed these data (Figure 3c). Pretreatment of
CD34þ HPCs with CHX before addition of TGF-b1 inhibited
the induction of epithelial genes within 6 hours (Figure 3d),
indicating that the observed epithelial gene induction in LCs
by TGF-b1 requires new protein synthesis. In conclusion, LC
differentiation in response to TGF-b1 is accompanied by the
induction of multiple epithelial genes.
1,25VD3 promotes LC differentiation along with epithelial gene
expression
Previous studies in epithelial cell lines showed that b-catenin
is a ligand-dependent coactivator of vitamin D receptor (VDR;
Palmer et al., 2001), and VDR requires its AF2 domain to
interact with the recruited nuclear receptor coactivators
(Jimenez-Lara and Aranda, 1999). Moreover, it is known that
epithelial adhesion molecules are positively regulated by
VD3/VDR signaling because of the presence of vitamin D
response elements (Palmer et al., 2001). Therefore, we studied
the effects of 1a,25-dihydroxyvitamin D3 (1,25VD3) on LC
differentiation and epithelial gene expression. The vitamin D
metabolites 25VD3 and 1,25VD3 can be detected in human
skin (Gobel et al., 2009) and LCs express 1-hydroxylase
required for generating bioactive 1,25VD3 (Fritsche et al.,
2003; Hewison et al., 2003). Moreover, we have already
described that the ectopic expression of the VDR promotes
TGF-b1-dependent LC differentiation and an inhibitor of VDR/
RXRa interfered with LC generation (Gobel et al., 2009). We
added 1,25VD3 to LC generation cultures from days 4 to 6
(Figure 4a). Percentages of CD1aþCD207þ cells were
enhanced upon 1,25VD3 addition as compared with control
(Figure 4b). Moreover, LCs generated in the presence of
1,25VD3 exhibited elevated expression levels of epithelial
molecules (Figure 4c). Inversely, b-catenin inhibition during
LC differentiation resulted in reduced expression of epithelial
genes (Supplementary Figure S4 online). Therefore, 1,25VD3
promotes LC differentiation and this effect is associated with
the enhancement of epithelial gene expression by LCs. In
addition, 1,25VD3 increased the expression levels of VDR,
TGF-b1, and b-catenin by LC precursors (Figure 4d), i.e.,
positive regulators of LC differentiation.
VDR promotes LC differentiation along with enhancement of
E-cadherin expression
The day 7–generated LCs (þ TGF-b1) expressed higher VDR
levels compared with monocytes (TGF-b1) (Figure 4e).
TGF-b1-mediated VDR induction did not require new protein
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Figure 1. Transforming growth factor-b1 (TGF-b1) induces b-catenin expression during Langerhans cell (LC) differentiation. (a) Immunofluorescence staining of
human skin sections for HLADR (red) and b-catenin (green). Nuclei were visualized with 4’,6-diamidino-2-phenylindole (DAPI). Scale bar¼10mm, n¼ 3.
(b) Quantitative real-time reverse-transcriptase–PCR (qRT–PCR) analysis of b-catenin expression in LC (þ TGF-b1) or monocyte ( TGF-b1) generation cultures at
day 7 (d7). Values were normalized to HPRT (n¼ 4, ±SD, *Po0.05). (c) CD34þ hematopoietic progenitor cells (HPCs) were pretreated with protein synthesis
inhibitor cyclohexamide (CHX) at a concentration of 0.05 ng ml 1 for 1 hour before addition of TGF-b1 (0.5 ng ml1). RNA samples were collected at 0 and
6 hours. mRNA of b-catenin was quantified by qRT–PCR (n¼4,±SD). (d) Cells analyzed for b-catenin, CD207, and CD14 expression. (e) b-Catenin immunoblot
analysis of day 7–generated cells compared with CD34þ cells.
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synthesis as revealed from CHX addition experiments. In fact,
VDR levels were higher in CHX-treated cells compared with
control, indicating that TGF-b1 may induce VDR together with
a VDR repressor or another negative regulator of VDR
(Figure 4f). Moreover, ectopic VDR promoted LC differentia-
tion, in keeping with the above-described positive effects of
VD3 on percentages of LCs (Figure 4b). Moreover, VDR-
transduced LCs exhibited increased levels of E-cadherin
expression compared with control-transduced cells
(Figure 4g and h).
b-Catenin cooperates with VDR during LC differentiation
We next analyzed whether ectopic VDR and b-catenin show
redundant or additional effects on LC generation. Combined
transduction of progenitor cells with VDR and b-catenin
resulted in the enhancement of LC differentiation relative to
each alone, with very high percentages of LCs generated from
double gene–transduced cells (Figure 5a). Moreover, the
coexpression of VDR.deltaAF2 with b-catenin diminished
the positive effect of b-catenin on LC differentiation
(Figure 5a), indicating that b-catenin requires VDR for promot-
ing LC differentiation from HPCs.
Accordingly, LC cultures supplemented with b-catenin
activator SB216763 plus 1,25VD3 exhibited consistently
increased percentages of LCs relative to cultures containing
each compound alone (n¼ 3, Figure 5b). Ectopic expression
of VDR resulted in elevated expression levels of b-catenin
(Supplementary Figure S5b online).In addition, the forced
expression of b-catenin resulted in slight increase in the
VDR expression (Supplementary Figure S5a online).
In subsequent experiments, we analyzed whether the b-
catenin effect on LC differentiation might depend on T-cell
factor (TCF) or VDR. If b-catenin forms a complex with VDR in
epithelial cell lines, it does not activate TCF-binding sites
(Palmer et al., 2001). LCs expressed significant levels of TCF
(Figure 5c) together with VDR (Figure 4e). We therefore asked
whether the b-catenin effect on LC differentiation might
depend on TCF or VDR. Cotransfection of HEK293 cells with
TCF reporter along with b-catenin and VDR confirmed the
previous observations (Palmer et al., 2001) that b-catenin
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Figure 2. b-Catenin promotes Langerhans cell (LC) differentiation. (a) CD34þ hematopoietic progenitor cells (HPCs) were transduced with retroviral vector
encoding b-catenin-IRES-GFP or empty control vector and cultured in LC/monocyte generation conditions (±transforming growth factor-b1 (TGF-b1)). Day 7
GFPþ cells were analyzed for CD1a and CD207. (b) CD34þ HPCs were transduced with lentiviral short hairpin RNA (shRNA)-b-catenin-pLKO1-eGFP and
cultured in LC generation conditions (þ TGF-b1). Day 7 GFPþ cells were analyzed for CD1a and CD207. (c) Schematic representation of experimental set up.
LC or monocyte (Mo) generation cultures (±TGF-b1) were initiated in the presence or absence of glycogen synthase kinase 3b (GSK3b) inhibitor±SB216763
(1 nMml1, n¼3). (d) FACS analysis of day 7–generated cells (±SB216763). Bar diagrams represent percentages and total numbers of CD1aþCD207þ cells
(n¼ 4). (e) Cell morphology of LC generation cultures (±SB216763). (f) Cells were labeled with carboxyfluorescein succinimidyl ester (CFSE) at day 0 and
analyzed at day 2 (n¼ 4). *P¼ 0.01; **P¼ 0.001.
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activated TCF reporter when expressed alone, whereas the
coexpression of VDR plus b-catenin completely abrogated
TCF reporter activity (Figure 5d). VDR/b-catenin expression
levels in gene-transduced LCs and transfected HEK293 cells
are likely similar. Although formal demonstration of this effect
in primary LCs was technically not feasible, these data
indicate that high VDR levels in LCs may compete with
TCF for b-catenin binding. These observations suggest that
LC differentiation is positively regulated by a similar VDR/b-
catenin interaction–dependent mechanism previously descri-
bed for epithelial cells.
VDR and b-catenin signaling promote the immunostimulatory
capacity of LCs
A hallmark characteristic of LCs is their potent capacity to
induce allogeneic T-cell proliferation. We therefore studied
whether treatment of LCs with 1,25VD3 and SB216763 (a
condition where b-catenin, VDR, and TGF-b1 are higher)
promotes the immunostimulatory capacity of LCs. LCs gener-
ated in the absence or presence of these compounds were
cocultured with allogeneic T cells. Cluster-purified LCs stimu-
lated with 1,25VD3 plus SB216763 exhibited a higher T-cell
proliferation capacity as compared with control cells
(Supplementary Figure S6 online).
In conclusion, we demonstrated that TGF-b1 coinduces
two transcription factors that enhance LC differentiation, i.e.,
b-catenin and VDR. According to our model, TGF-b1 and
vitamin D3, the two epidermal microenvironmental signals,
are critical for LC phenotype induction (Supplementary Figure
S7 online).
DISCUSSION
We here showed that among skin-resident monocyte/DC
family members, high levels of b-catenin expression are
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confined to epidermal LCs and that TGF-b1 induces b-catenin
in progenitor cells undergoing LC commitment. Our mechan-
istic data showed that b-catenin promotes LC differentiation
from HPCs. Moreover, we found that TGF-b1 and b-catenin
intersect with vitamin D signaling during LC differentiation.
First, 1,25VD3 stimulation of LC precursors increased the
expression levels of b-catenin along with TGF-b1 and VDR.
Accordingly, 1,25VD3 promoted the TGF-b1-induced expres-
sion of multiple epithelial genes by LCs. Second, the positive
effects of b-catenin on LC generation were diminished when a
mutant VDR lacking the previously defined VDR/b-catenin
physical interaction domain (i.e., VDR.deltaAF2) was coex-
pressed in HPCs. Therefore, VDR and b-catenin may represent
critical positive regulators of LC differentiation.
VDR is downregulated during monocyte-derived DC differ-
entiation (Hewison et al., 2003) and inhibits DC maturation
(Griffin et al., 2000). Therefore, among DC family members a
possible cooperative effect of VDR and b-catenin might be
specific for LC development and maintenance. In support of
this assumption, VDR inhibition impaired LC generation
in vitro (Gobel et al., 2009) and VDR / LCs were
deficient in proliferation in response to a topically applied
VD3 proinflammatory agonist (Chorro et al., 2009).
Interestingly, as epidermal tropism of T cells is mediated by
1,25VD3 derived from epidermal LCs (Sigmundsdottir et al.,
2007), 1,25VD3-mediated enhancement of LC differentiation
may contribute to epithelial programming of T cells.
We showed that TGF-b1-induced LCs express multiple
epithelial genes. It was previously described that LCs express
E-cadherin, EpCAM, and claudin-1 (Riedl et al., 2000b;
Zimmerli and Hauser, 2007; Eisenwort et al., 2011; Gaiser
et al., 2012). Moreover, we recently described that TGF-b1
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**P¼0.008; ***P¼ 0.001.
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induces the epithelial molecule TROP2 (TACSTD2) during LC
differentiation (Eisenwort et al., 2011). Here, we showed that
LCs express several additional epithelial adhesion molecules,
i.e., CK18, CK8, ZO3, JAM-1, and Ocln. Together, these data
indicate that TGF-b1 induces an epithelial gene expression
program during LC differentiation from HPCs.
We provided evidence for a role of VDR and b-catenin
during LC differentiation downstream of TGF-b1 and VD3.
Studies in epithelial cells previously identified a critical
physical interaction between VDR and b-catenin during
differentiation and epithelial gene expression. b-Catenin spe-
cifically activates VDR at the expense of TCF transcriptional
activity depending on the availability of either factor (Palmer
et al., 2001). For example, during hair follicle differentiation,
combined activation of VDR and b-catenin signaling
promoted the formation of VDR/b-catenin complexes
(Palmer et al., 2008). The VDR.deltaAF2 mutant used in our
study was previously used to demonstrate the formation of
functional VDR/b-catenin complexes in epithelial cells
(Shah et al., 2006). We here described that VDR.
deltaAF2 diminishes the positive effects of b-catenin on LC
differentiation, indicating that LC differentiation is positively
regulated by the same VDR/b-catenin cooperation previously
established in epithelial cells. This model is further supported
by the findings that 1,25VD3 promoted epithelial gene
expression of LCs and that the ectopic coexpression of VDR
plus b-catenin resulted in substantially elevated percentages of
generated LCs relative to each factor alone. Lentiviral short
hairpin RNA knockdown resulted in reduced b-catenin
expression levels, and this effect correlated with reduced per-
centages of generated LCs. Importantly, b-catenin was only
partially inhibited in these experiments. Whether b-catenin is
strictly required for LC differentiation remains to be studied.
Our observation that TGF-b1 induces b-catenin in HPCs
undergoing LC commitment is reminiscent of the demonstra-
tion that nuclear translocation of b-catenin in bone marrow–
derived mesenchymal stem cells occurs through the
activation of the TGF-b1 signaling pathway (Jian et al.,
2006). In contrast, our observations that ectopic VDR
promotes TGF-b1-dependent LC differentiation in the
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Figure 5. Positive effects of b-catenin and VD3/vitamin D receptor (VDR) during Langerhans cell (LC) differentiation. (a) CD34þ hematopoietic progenitor
cells (HPCs) were transduced with vectors encoding VDR-IRES-GFP, b-catenin-IRES-NGFR, or VDR-delta AF2-IRES-GFP. FACS plots represent day
7–generated GFPþ cells. Bar diagrams represent percentages of CD1aþCD207þ cells among GFPþ cells (n¼ 3, *Po0.05). (b) LCs were treated with SB216763
and/or 1a,25-dihydroxyvitamin D3 (1,25VD3) as above (Figures 2c and 4a) and analyzed at day 7. Bar diagrams represent percentages and total numbers of
CD1aþCD207þ cells (n¼ 3, *Po0.05). NS, not significant. (c) Quantitative real-time reverse-transcriptase–PCR (qRT–PCR) analysis of T-cell factor (TCF) by day
7–generated LCs (n¼ 3,±SD, *Po0.05). (d) HEK293 cells cotransfected with a TCF/LEF reporter and expression plasmids. Luciferase values were normalized to
b-galactosidase (b-gal; n¼3). **P¼0.001.
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absence of vitamin D supplementation might be related to the
findings that the in vitro binding of VDR and Smad3 is ligand
independent (Yanagisawa et al., 1999).
Our data indicate that the two microenvironmental signals
VD3 and TGF-b1 intersect for inducing LC differentiation and
associated epithelial gene expression. Interestingly, b-catenin
(Manicassamy et al., 2010), VD3/VDR (Adorini et al., 2003),
TGF-b1 (Kaplan, 2010), and E-cadherin (Jiang et al., 2007)
have previously been implicated in the generation of
tolerogenic DCs, and 1,25VD3 stimulation of LCs enhance
their capacity to induce regulatory T cells (van der Aar et al.,
2011). Augmentation of LC phenotypic characteristics by
these signals is in line with the recent demonstration that
LCs exert a regulatory function in vivo (Kaplan, 2010).
Enhancement of mixed leukocyte reaction activity by LCs
upon VD3 plus GSK3b inhibitor treatment correlated with the
augmentation of LC phenotypic characteristics. Therefore,
these compounds might be added to LC generation cultures
to obtain potent antigen-presenting LCs ex vivo for basic and
clinically oriented studies. The observed enhanced allogeneic-
mixed leukocyte reaction activity by VD3/b-catenin agonist–
treated LC precursors is supportive of our phenotypic data that
these signaling pathways promote LC differentiation from
progenitor cells.
Inducible LC-specific abrogation of autocrine/paracrine
TGF-b1 signaling led to the migration of epidermal LCs into
skin-draining lymph nodes, with migrated LCs maintaining the
phenotype of homeostatically migrated nonactivated LCs
(Bobr et al., 2012), a phenotype similar to partially activated
LCs in response to cluster disruption and concomitant
b-catenin activation (Jiang et al., 2007). Our study shows
that b-catenin and E-cadherin are coinduced during TGF-b1-
dependent LC differentiation, supporting that b-catenin
represents an important signaling molecule during LC
activation. However, we did not study LC activation/
maturation; therefore, it will be interesting to study the roles
of TGF-b1 and E-cadherin/b-catenin signaling during these
processes using the in vitro model described here.
MATERIALS AND METHODS
Cytokines and reagents
Human stem cell factor, thrombopoietin, tumor necrosis factor-a,
GM-CSF, and fms-related tyrosine kinase 3 ligand were obtained from
PeproTech (London, UK); TGF-b1 was purchased from R&D Systems
(Wiesbaden, Germany). GSK3b inhibitor (SB216763), CHX (C-6255),
and 1,25VD3 were purchased from Sigma-Aldrich (St Louis, MO).
Isolation and in vitro culture of CD34þ cord blood cells
CD34þ cells were isolated as previously described (Taschner et al.,
2007). LC generation cultures were set up according to a previously
described protocol (Strobl et al., 1997). LC clusters were purified as
described before (Gatti et al., 2000).
qRT–PCR
Quantitative qRT–PCR analysis was performed as previously
described (Platzer et al., 2009). The qRT–PCR primers are described
in Supplementary Table S1 online.
Retroviral vectors, transfection of packaging cell lines, and gene
transduction
MIG-I-GFP-b-catenin-wt-HA and MIG-I-NGFR-b-catenin-wt-HA
were obtained by cutting pCDNA3-b-catenin-wt-HA (kind gift of
Dr Stephen W Byers; Shah et al., 2006) with BamHI and inserting it
into BglII site of MIG-I-GFP and MIG-I-NGFR vectors. VDR-GFP was
previously described (Gobel et al., 2009). PBMN-I-GFP-
VDR.deltaAF2 was obtained by cutting pGEX.2T-VDR.deltaAF2
(kind gift of Dr Ana Aranda; Jimenez-Lara and Aranda, 1999) with
EcoRI and BamHI and cloning into PBMN-I-GFP vector. Short hairpin
RNA-b-catenin-pLKO1 was a kind gift of Dr Elena Siapati (Siapati
et al., 2011). Transfection as well as infection of target cells was
described previously (Platzer et al., 2004).
Western blot analysis
Western blot analysis was performed as previously described (Jurkin
et al., 2010). Membranes were probed with antibodies against
rabbit-a-actin (A-2066; Sigma, Vienna, Austria), rabbit-a-VDR(H81)
(Santa Cruz Biotechnology, Santa Cruz, CA), mouse-b-catenin
(8E4) (nanoTools, Teningen, Germany), followed by horseradish
peroxidase–conjugated goat anti-rabbit IgG antibodies or goat anti-
mouse IgG antibodies (Pierce Biotechnology, Rockford, IL).
Flow cytometry
Flow cytometry staining and analysis were performed as described
(Platzer et al., 2004). Murine mAbs of the following specificities were
used: FITC-conjugated mAb specific for CD14; biotinylated mAb
specific for aNGFR, conjugated with streptavidin-PerCP (BD
Biosciences, Palo Alto, CA); phycoerythrin-conjugated mAb specific
for CD207 (Immunotech, Marseille, France); allophycocyanin-
conjugated antibody specific for CD324 and Pacific Blue–
conjugated CD1a (BioLegend, San Diego, CA). For intracellular
staining, cells were fixed with fixation medium (An der Grub,
Kaumberg, Austria) for 5 minutes at room temperature and permea-
bilized with permeabilization medium (An der Grub). Later, cells
were stained with mAbs specific for CK18, CK8 (Sigma-Aldrich),
claudin-1 (Zymed Laboratories, Vienna, Austria), polyclonal antibo-
dies specific for JAM-1, ZO3, and Ocln (Invitrogen, Vienna, Austria),
or isotype controls (Cell Signaling Technologies, Beverly, MA).
Second-step reagent was Alexa 647–labeled goat anti-rabbit IgG or
rabbit anti-mouse IgG (Invitrogen). Flow cytometric analysis was
performed using a LSRII instrument (BD Biosciences) and the FlowJo
software (Tree Star, Ashland, OR).
Immunohistochemistry
Human tissue specimens were stained as described (Eisenwort et al.,
2011). For detection of b-catenin antibody, slides were probed with a
polyclonal donkey-anti-mouse Alexa-Fluor-488-conjugated antibody
(Invitrogen). The biotin-labeled HLA-DR antibody was detected using
streptavidin-phycoerythrin (BD Biosciences). Nuclei were stained with
4’,6-diamidino-2-phenylindole. Pictures were taken using an LSM700
microscope and Zen 2009 software (Carl Zeiss, Vienna, Austria).
Luciferase assay
Luciferase assay was performed as previously described (Jurkin et al.,
2010). 293T cells were transfected with the TCF/LEF reporter
luciferase construct, kindly provided by Dr Peter Petzelbauer
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(Department of Dermatology, Medical University of Vienna, Vienna,
Austria) or empty control vector or the indicated expression plasmids.
T-cell proliferation assays
T-cell proliferation assay was performed as described before (Stockl
et al., 1999). Assays were performed in triplicates.
Statistical analysis
Statistical analysis was performed using the paired, two-tailed
Student’s t-test or analysis of variance; P-values of o0.05 were
considered significant.
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